Omnicell Net Profit Margin 2010-2024 | OMCL
Omnicell net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Omnicell Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-09-30 |
$1.06B |
$-0.02B |
-1.60% |
| 2024-06-30 |
$1.08B |
$-0.02B |
-1.85% |
| 2024-03-31 |
$1.10B |
$-0.02B |
-1.90% |
| 2023-12-31 |
$1.15B |
$-0.02B |
-1.74% |
| 2023-09-30 |
$1.19B |
$-0.03B |
-2.86% |
| 2023-06-30 |
$1.24B |
$-0.02B |
-1.86% |
| 2023-03-31 |
$1.27B |
$-0.02B |
-1.34% |
| 2022-12-31 |
$1.30B |
$0.01B |
0.46% |
| 2022-09-30 |
$1.31B |
$0.05B |
3.67% |
| 2022-06-30 |
$1.26B |
$0.06B |
4.77% |
| 2022-03-31 |
$1.20B |
$0.07B |
5.92% |
| 2021-12-31 |
$1.13B |
$0.08B |
6.80% |
| 2021-09-30 |
$1.07B |
$0.08B |
7.38% |
| 2021-06-30 |
$0.99B |
$0.06B |
5.97% |
| 2021-03-31 |
$0.92B |
$0.04B |
3.83% |
| 2020-12-31 |
$0.89B |
$0.03B |
3.58% |
| 2020-09-30 |
$0.89B |
$0.04B |
4.26% |
| 2020-06-30 |
$0.91B |
$0.05B |
5.40% |
| 2020-03-31 |
$0.92B |
$0.07B |
7.47% |
| 2019-12-31 |
$0.90B |
$0.06B |
6.80% |
| 2019-09-30 |
$0.86B |
$0.05B |
6.27% |
| 2019-06-30 |
$0.84B |
$0.05B |
5.74% |
| 2019-03-31 |
$0.81B |
$0.04B |
4.83% |
| 2018-12-31 |
$0.79B |
$0.04B |
4.95% |
| 2018-09-30 |
$0.77B |
$0.06B |
7.12% |
| 2018-06-30 |
$0.76B |
$0.05B |
6.49% |
| 2018-03-31 |
$0.75B |
$0.04B |
5.89% |
| 2017-12-31 |
$0.71B |
$0.03B |
4.35% |
| 2017-09-30 |
$0.69B |
$0.01B |
1.30% |
| 2017-06-30 |
$0.68B |
$0.00B |
0.44% |
| 2017-03-31 |
$0.67B |
$-0.00B |
0.00% |
| 2016-12-31 |
$0.70B |
$0.01B |
1.44% |
| 2016-09-30 |
$0.65B |
$0.01B |
1.38% |
| 2016-06-30 |
$0.60B |
$0.02B |
2.50% |
| 2016-03-31 |
$0.54B |
$0.03B |
4.64% |
| 2015-12-31 |
$0.48B |
$0.03B |
6.40% |
| 2015-09-30 |
$0.48B |
$0.03B |
6.72% |
| 2015-06-30 |
$0.46B |
$0.03B |
6.68% |
| 2015-03-31 |
$0.46B |
$0.03B |
6.58% |
| 2014-12-31 |
$0.44B |
$0.03B |
6.79% |
| 2014-09-30 |
$0.43B |
$0.03B |
6.57% |
| 2014-06-30 |
$0.41B |
$0.03B |
7.13% |
| 2014-03-31 |
$0.40B |
$0.03B |
6.82% |
| 2013-12-31 |
$0.38B |
$0.02B |
6.30% |
| 2013-09-30 |
$0.37B |
$0.02B |
6.30% |
| 2013-06-30 |
$0.36B |
$0.02B |
6.20% |
| 2013-03-31 |
$0.34B |
$0.02B |
5.06% |
| 2012-12-31 |
$0.31B |
$0.02B |
5.11% |
| 2012-09-30 |
$0.29B |
$0.01B |
4.90% |
| 2012-06-30 |
$0.27B |
$0.01B |
3.76% |
| 2012-03-31 |
$0.25B |
$0.01B |
4.76% |
| 2011-12-31 |
$0.25B |
$0.01B |
4.49% |
| 2011-09-30 |
$0.24B |
$0.01B |
3.35% |
| 2011-06-30 |
$0.23B |
$0.01B |
2.60% |
| 2011-03-31 |
$0.23B |
$0.01B |
2.22% |
| 2010-12-31 |
$0.22B |
$0.01B |
2.25% |
| 2010-09-30 |
$0.22B |
$0.01B |
2.27% |
| 2010-06-30 |
$0.22B |
$0.01B |
2.29% |
| 2010-03-31 |
$0.22B |
$0.00B |
1.85% |
| 2009-12-31 |
$0.21B |
$0.00B |
0.47% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$2.264B |
$1.147B |
|
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
|
